Jörres RA - Search Results

1

High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study.

Waschki B, Alter P, Zeller T, Magnussen C, Neumann JT, Twerenbold R, Sinning C, Herr C, Kahnert K, Fähndrich S, Blankenberg S, Rabe KF, Welte T, Jörres RA, Vogelmeier CF, Bals R, Watz H; German COSYCONET Cohort. Waschki B, et al. Among authors: jorres ra. Eur Respir J. 2020 Feb 27;55(2):1901314. doi: 10.1183/13993003.01314-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 31831579 Free article.

2

Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.

Nowak D, Jörres R, Rabe KF, Lüthke M, Wiessmann J, Magnussen H. Nowak D, et al. Eur J Clin Pharmacol. 1992;43(6):591-5. doi: 10.1007/BF02284956. Eur J Clin Pharmacol. 1992. PMID: 1493839 Clinical Trial.

3

Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.

Wegner RE, Jörres RA, Kirsten DK, Magnussen H. Wegner RE, et al. Among authors: jorres ra. Eur Respir J. 1994 Apr;7(4):725-9. doi: 10.1183/09031936.94.07040725. Eur Respir J. 1994. PMID: 8005256 Free article.

4

The effect of 10, 50 and 200 micrograms inhaled fenoterol on exercise induced asthma.

Rabe KF, Jörres R, Magnussen H. Rabe KF, et al. Clin Exp Allergy. 1993 May;23(5):440-5. doi: 10.1111/j.1365-2222.1993.tb00351.x. Clin Exp Allergy. 1993. PMID: 8334542 Clinical Trial.

5

Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects.

Nowak D, Grimminger F, Jörres R, Oldigs M, Rabe KF, Seeger W, Magnussen H. Nowak D, et al. Eur Respir J. 1993 Mar;6(3):405-12. Eur Respir J. 1993. PMID: 8386107

6

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.

Rabe KF, Jörres R, Nowak D, Behr N, Magnussen H. Rabe KF, et al. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1436-41. doi: 10.1164/ajrccm/147.6_Pt_1.1436. Am Rev Respir Dis. 1993. PMID: 8503554 Clinical Trial.

7

Reproducibility of airway response to inhaled bradykinin and effect of the neurokinin receptor antagonist FK-224 in asthmatic subjects.

Schmidt D, Jörres RA, Rabe KF, Magnussen H. Schmidt D, et al. Among authors: jorres ra. Eur J Clin Pharmacol. 1996;50(4):269-73. doi: 10.1007/s002280050106. Eur J Clin Pharmacol. 1996. PMID: 8803517 Clinical Trial.

8

[Tachyphylaxis of airway response to inhaled bradykinin over several days].

Schmidt D, Jörres RA, Rabe KF, Magnussen H. Schmidt D, et al. Among authors: jorres ra. Pneumologie. 1996 Nov;50(11):779-82. Pneumologie. 1996. PMID: 9082446 German.

9

Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.

Taube C, Kanniess F, Grönke L, Richter K, Mücke M, Paasch K, Eichler G, Jörres RA, Magnussen H. Taube C, et al. Among authors: jorres ra. Respir Med. 2003 May;97(5):568-77. doi: 10.1053/rmed.2001.1411. Respir Med. 2003. PMID: 12735677 Free article. Clinical Trial.

10

Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.

Zühlke IE, Kanniess F, Richter K, Nielsen-Gode D, Böhme S, Jörres RA, Magnussen H. Zühlke IE, et al. Among authors: jorres ra. Eur Respir J. 2003 Dec;22(6):926-30. doi: 10.1183/09031936.03.00046203. Eur Respir J. 2003. PMID: 14680080 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters